Company intelligence / Profile preview

Supo Technology

Suzhou, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Supo Technology is a biotechnology company specializing in the development and clinical application of exosome-based technologies. Based in Suzhou, China, the company focuses on high-efficiency exosome isolation, purification, and the development of exosome-based drug delivery systems and diagnostic tools. Their platform aims to leverage the natural properties of exosomes for targeted therapy in oncology and other complex diseases. Supo Technology provides both proprietary therapeutic programs and technical services to the broader life sciences community.

Therapeutic areas: OncologyImmunology
Modalities: Exosome-based therapySmall moleculeRNA therapy
Industry: Biotech

Beyond the preview

Go deeper on Supo Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Supo Technology.

Explore the full profile